Tom Wilton
Corporate Officer/Principal chez CARISMA THERAPEUTICS, INC.
Profil
Tom Wilton is currently the Chief Business Officer at LogicBio Therapeutics, Inc. and Carisma Therapeutics, Inc. He is a graduate of Brunel University, the University of Leeds, and the University of London.
Postes actifs de Tom Wilton
| Sociétés | Poste | Début |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2019 |
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Tom Wilton
| University of London | Undergraduate Degree |
| University of Leeds | Graduate Degree |
| Brunel University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
